Sowell Financial Services’s Cocrystal Pharma COCP Stock Holding History

Sowell Financial Services’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-15	Closed	–	–	942
2021 Q1	$0	Hold	15	–	–	﹤0.01%	3131
2020 Q4	$0	Buy	+15	New	+$208	﹤0.01%	2710

Other funds holding COCP

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Sowell Financial Services's COCP Position: Q2 2021 in Review

Sowell Financial Services sold out of Cocrystal Pharma (COCP) in Q2 2021, closing a stake of 15 shares.

Sowell Financial Services first reported a position in COCP in Q4 2020 and held it in 2 quarters. The position peaked at $0 in Q1 2021. 42 funds tracked by Wall St. Rank hold COCP as of Q2 2021.

Sowell Financial Services reported no remaining Cocrystal Pharma position as of Q2 2021 after selling out during the quarter.
Sowell Financial Services sold 15 Cocrystal Pharma shares in Q2 2021.
Sowell Financial Services first reported a position in Cocrystal Pharma in Q4 2020 and held it in 2 quarters.
Sowell Financial Services's Cocrystal Pharma position peaked at $0 in Q1 2021.
42 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.